English | 简体中文 | 繁體中文 | 한국어 | 日本語
 Latest Press Releases
Friday, June 13, 2025
雅各臣公佈二零二五財年全年業績 持續經營業務溢利飈升43.1%至3.0億港元
19:06 HKT/SGT
Desert Mirage or Musical Revolution? ESCAPE Records' Secret Vault Opens, Revealing a Hidden Sonic Sanctuary
19:00 HKT/SGT
雅各臣公布二零二五财年全年业绩 持续经营业务溢利飙升43.1%至3.0亿港元
18:53 HKT/SGT
第八届贸发局「创业快綫」10间优胜初创诞生
16:38 HKT/SGT
第八屆貿發局「創業快綫」10間優勝初創誕生
15:53 HKT/SGT
Ria Money Transfer's New Approval Enables Digital Salary Payments for Malaysia's Migrant Workforce
12:00 HKT/SGT
TRENDE Announces Strategic Capital and Business Alliance with Tokyu Land
12:00 HKT/SGT
ARE Expands India Leadership, Strengthens Regional Role in Climate, Energy, and Food System Transition
11:46 HKT/SGT
Thursday, June 12, 2025
JBM Healthcare Delivers Strong FY2025 Annual Results, Net Profit Surged 51.2% to HK$197.3 Million
21:07 HKT/SGT
健倍苗苗二零二五財年全年業績表現亮眼 純利飆升51.2%至1.97億港元
20:58 HKT/SGT
健倍苗苗二零二五财年全年业绩表现亮眼 纯利飙升51.2%至1.97亿港元
20:48 HKT/SGT
品質基石的守護者:檢測檢驗行業賦能高質量發展
18:28 HKT/SGT
质量基石的守护者:检测检验行业赋能高质量发展
18:19 HKT/SGT
NEFECON(R) and EVER001 Drive Synergistic Progress as Everest Medicines Advances
17:38 HKT/SGT
NEFECON(R) and EVER001 Drive Synergistic Progress as Everest Medicines Advances
16:38 HKT/SGT
耐賦康(R)與EVER001協同發力 雲頂新耀推動腎病治療進入精準管理新階段
16:31 HKT/SGT
耐赋康(R)与EVER001协同发力 云顶新耀推动肾病治疗进入精准管理新阶段
16:26 HKT/SGT
10 winners selected at 8th edition of Start-up Express
12:29 HKT/SGT
LEGENDARY HUMANITY Announces Strategic Bitcoin Reserves and Enhancements to the VIVI Token Ecosystem
09:00 HKT/SGT
LEGENDARY HUMANITY Announces Strategic Bitcoin Reserves and Enhancements to the VIVI Token Ecosystem
08:00 HKT/SGT
Wednesday, June 11, 2025
This Technology is Conquering the World: Neutrinovoltaics Redefining Global Infrastructure
21:00 HKT/SGT
這項技術正在征服世界:中微子光電技術正在重新定義全球基礎設施
21:00 HKT/SGT
这项技术正在征服世界:中微子光伏技术正在重新定义全球基础设施
21:00 HKT/SGT
HKTDC Design Gallery x STICKYLINE present: "Love HK" Exhibition
13:34 HKT/SGT
英國國防部與通用原子航空系統公司簽署「保護者」支援合約
13:00 HKT/SGT
英国国防部与通用原子航空系统公司签署“保护者”支持合同
12:58 HKT/SGT
三菱重工、バイオエタノールを活用したクリーン燃料の製造技術を開発するiPEACE223社に出資
11:40 HKT/SGT
Blockpass partners with CryptoSwift to deliver global Travel Rule Compliance
10:00 HKT/SGT
Tuesday, June 10, 2025
爆款IPO前瞻:「香水第一股」穎通控股強勢登場!港股IPO再現黃金賽道 龍頭勢掀「嗅覺經濟」新浪潮
19:10 HKT/SGT
爆款IPO前瞻:“香水第一股”颖通控股强势登场!港股IPO再现黄金赛道 龙头势掀“嗅觉经济”新浪潮
19:10 HKT/SGT
U.S. Polo Assn. Returns as Official Apparel and Jersey Partner for Chestertons Polo in the Park in Downtown London
19:00 HKT/SGT
Supercomputer Fugaku retains first place worldwide in Graph500 rankings
18:47 HKT/SGT
ダイムラートラック、三菱ふそう、日野、トヨタ、三菱ふそうと日野の統合に関する最終合意を締結
16:30 HKT/SGT
聯想控股副總裁于浩:在技術變革中錨定「長期主義」
15:37 HKT/SGT
联想控股副总裁于浩:在技术变革中锚定"长期主义"
15:28 HKT/SGT
Ai sẽ là người đầu tiên ghi danh vào lịch sử với tư cách là Nhà Vô Địch Thế Giới đầu tiên?!
14:00 HKT/SGT
Siapakah yang akan mengukir nama dalam sejarah sebagai "Juara Dunia Pertama"!
14:00 HKT/SGT
Siapakah yang akan mengukir namanya dalam sejarah sebagai “Juara Dunia Pertama”!
14:00 HKT/SGT
誰將成為名留青史的「初代世界冠軍」!
14:00 HKT/SGT
UK MOD Signs Protector Support Contract with GA-ASI
06:00 HKT/SGT
Monday, June 9, 2025
New HKTDC Chairman Frederick Ma keen to promote Hong Kong as best partner for global enterprises
19:30 HKT/SGT
SRKay Consulting Group Releases Research Report: 'From Legal Frameworks to Successful Operations'--A Strategic Playbook for India Market Entry
17:00 HKT/SGT
Everest Medicines Presents Positive Results from Phase 1b/2a Clinical Trial of EVER001 for Primary Membranous Nephropathy at ERA 2025
12:52 HKT/SGT
雲頂新耀EVER001亮相ERA 2025 探索原發性膜性腎病治療新路徑
12:47 HKT/SGT
云顶新耀EVER001亮相ERA 2025 探索原发性膜性肾病治疗新路径
12:35 HKT/SGT
 ACN Search:
 
Abdullah Ayed Al Mazny, General Manager at Desert Dragon (ICS Arabia), and Ghufran Hamid, CEO of XDS, at the '10Mw Immersive Cooling for Ai Worlkload' Signing Ceremony on July 8, 2025.
 
Daily Newsletter
Browse Press Releases
Press Releases by Industry »
Press Releases by Language »
Multimedia Press Releases »
Events newsroom »
 Events:
More events >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575